2020 ASCO Virtual Direct™ Highlights

 

Skin
11:28

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Melanoma Updates: Optimal Dosing Schedule of Neoadjuvant Ipi + Nivo, Adjuvant Pembro in Resected High-Risk Stage III, Adjuvant Dabrafenib + Trametinib in BRAF V600E Stage III, Pembro vs. Ipi in Advanced Melanoma

FEATURING Ari VanderWalde
  • 91 views
  • August 25, 2020
16:13

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Melanoma Updates: Combination ICI Post PD-1 Failure, Alternative Dosing of Combination ICI, and New Therapies Toripalimab+Axitinib and Lifileucel TIL

FEATURING Ari VanderWalde
  • 57 views
  • August 25, 2020